HealthEquity, Inc.
103.97USD
+3.0000 (+2.97%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on HQY.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.15▼ | $1.15 | 5 | 6 |
| Next quarter | $1.1▼ | $1.13 | 1 | 13 |
| Current year | $4.72▲ | $4.72 | 7 | 2 |
| Next year | $5.5▲ | $5.45 | 7 | 4 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $1.19 | $1.24 | +0.05 (+3.9%) |
| 2026-04-30 | $1.12 | $1.24 | +0.12 (+11.2%) |
| 2026-01-31 | $0.9 | $0.95 | +0.05 (+5.8%) |
| 2025-10-31 | $0.91 | $1.01 | +0.10 (+10.7%) |
211 ratings from 26 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| BMO Capital | Maintained | Outperform | $105 $125 | Oct 21, 2026 |
| Barclays | Maintained | Overweight | $110 $115 | Sep 18, 2026 |
| Deutsche Bank | Maintained | Buy | $135 $142 | Aug 31, 2026 |
| BTIG | Reiterated | Buy | $115 | Aug 28, 2026 |
| BTIG | Maintained | Buy | $110 $115 | Jul 24, 2026 |
| RBC Capital | Reiterated | Outperform | $108 | Jun 3, 2026 |
| Citizens | Maintained | Market Outperform | $110 $111 | Jun 1, 2026 |
| RBC Capital | Maintained | Outperform | $100 $108 | May 29, 2026 |
| Barrington Research | Maintained | Outperform | $110 | May 22, 2026 |
| BMO Capital | Upgraded from Market Perform | Outperform | $85 $105 | Apr 9, 2026 |
| Deutsche Bank | Maintained | Buy | $120 $128 | Mar 19, 2026 |
| Barrington Research | Maintained | Outperform | $125 $110 | Mar 18, 2026 |
| JP Morgan | Maintained | Overweight | $129 $123 | Mar 18, 2026 |
| RBC Capital | Maintained | Outperform | $110 $100 | Mar 18, 2026 |
| Barclays | Maintained | Overweight | $118 $110 | Feb 18, 2026 |
| BTIG | Maintained | Buy | $130 $110 | Feb 17, 2026 |
| Goldman Sachs | Downgraded from Neutral | Sell | $89 | Jan 9, 2026 |
| Keybanc | Maintained | Overweight | $120 $125 | Jan 8, 2026 |
| Barclays | Initiated | Overweight | $118 | Dec 9, 2025 |
| Barrington Research | Maintained | Outperform | $125 | Dec 4, 2025 |
| JP Morgan | Maintained | Overweight | $126 $129 | Dec 4, 2025 |
| Citizens | Maintained | Market Outperform | $117 $122 | Dec 4, 2025 |
| BTIG | Reiterated | Buy | $130 | Dec 4, 2025 |
| BMO Capital | Initiated | Market Perform | $100 | Nov 13, 2025 |
| Keybanc | Maintained | Overweight | $125 $120 | Oct 8, 2025 |
68 filings from 23 insiders · 11 buy / 7 sell over 6m
Officers and directors of HQY, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Rajasekar SunilOfficer, EVP Chief Prod & Strat Officer | Buy | 108 | $90.33 | $10k | Oct 15, 2026 |
| Gathright MichaelOfficer, Chief Customer Officer | Tax | 662 | $91.16 | $60k | Oct 6, 2026 |
| Fiore Michael HenryFormer EVP, CCO | Tax | 2.0k | $91.16 | $185k | Oct 6, 2026 |
| Cutler ScottDirector; Officer, President and CEO | Tax | 1.2k | $91.16 | $112k | Oct 6, 2026 |
| Ladd DelanoOfficer, EVP, General Counsel | Tax | 1.1k | $91.16 | $98k | Oct 6, 2026 |
| Lucania James MOfficer, EVP & CFO | Tax | 2.8k | $91.16 | $257k | Oct 6, 2026 |
| Neeleman StephenDirector; Officer, FOUNDER AND VICE CHAIRMAN | Tax | 1.1k | $91.16 | $100k | Oct 6, 2026 |
| Neeleman StephenDirector; Officer, FOUNDER AND VICE CHAIRMAN | Giftindirect | 1.5k | — | — | Sep 17, 2026 |
| Rajasekar SunilOfficer, EVP Chief Prod & Strat Officer | Sell | 108 | $105.60 | $11k | Aug 24, 2026 |
| Rajasekar SunilOfficer, EVP Chief Prod & Strat Officer | Buy | 23 | $95.06 | $2k | Jul 8, 2026 |
| Rajasekar SunilOfficer, EVP Chief Prod & Strat Officer | Sell | 23 | $82.81 | $2k | Apr 22, 2026 |
| NEELEMAN STEPHENOfficer and Director | Grant | 39.8k | — | — | Mar 25, 2026 |
| ROSNER ELIMELECHChief Technology Officer | Grant | 60.6k | — | — | Mar 25, 2026 |
| FIORE MICHAEL HENRYOfficer | Grant | 17.6k | — | — | Mar 25, 2026 |
| GATHRIGHT MICHAELOfficer | Grant | 15.2k | — | — | Mar 25, 2026 |
| LUCANIA JAMES MChief Financial Officer | Grant | 27.3k | — | — | Mar 25, 2026 |
| LADD DELANO W IVGeneral Counsel | Grant | 35.6k | — | — | Mar 25, 2026 |
| CUTLER SCOTT RAYMONDChief Executive Officer | Grant | 72.8k | — | — | Mar 25, 2026 |
| NATARAJAN RAJESHDirector | Grant | 976 | — | — | Feb 2, 2026 |
| PARKER STUART BDirector | Grant | 1.3k | — | — | Feb 2, 2026 |
No analyst notes on HQY yet.
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 10 | 0 | 0 | 0 | Buy1.67 |
| 1 mo ago | 5 | 10 | 0 | 0 | 0 | Buy1.67 |
| 2 mo ago | 5 | 10 | 0 | 0 | 0 | Buy1.67 |
| 3 mo ago | 5 | 10 | 0 | 0 | 0 | Buy1.67 |
Members whose judged calls on HQY have played out most reliably.
No settled calls on HQY yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice